266 related articles for article (PubMed ID: 20930707)
1. Adiponectin and hypertension.
Ohashi K; Ouchi N; Matsuzawa Y
Am J Hypertens; 2011 Mar; 24(3):263-9. PubMed ID: 20930707
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin: a key adipocytokine in metabolic syndrome.
Okamoto Y; Kihara S; Funahashi T; Matsuzawa Y; Libby P
Clin Sci (Lond); 2006 Mar; 110(3):267-78. PubMed ID: 16464169
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome and adipocytokines.
Matsuzawa Y
FEBS Lett; 2006 May; 580(12):2917-21. PubMed ID: 16674947
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin: linking the metabolic syndrome to its cardiovascular consequences.
Rabin KR; Kamari Y; Avni I; Grossman E; Sharabi Y
Expert Rev Cardiovasc Ther; 2005 May; 3(3):465-71. PubMed ID: 15889974
[TBL] [Abstract][Full Text] [Related]
5. The role of adiponectin in metabolic and vascular disease: a review.
Cui J; Panse S; Falkner B
Clin Nephrol; 2011 Jan; 75(1):26-33. PubMed ID: 21176748
[TBL] [Abstract][Full Text] [Related]
6. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease.
Matsuzawa Y
Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):35-42. PubMed ID: 16391616
[TBL] [Abstract][Full Text] [Related]
7. Adipocytokines and metabolic syndrome.
Matsuzawa Y
Semin Vasc Med; 2005 Feb; 5(1):34-9. PubMed ID: 15968578
[TBL] [Abstract][Full Text] [Related]
8. White adipose tissue and cardiovascular disease.
Matsuzawa Y
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):637-47. PubMed ID: 16311222
[TBL] [Abstract][Full Text] [Related]
9. Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction.
Guzik TJ; Marvar PJ; Czesnikiewicz-Guzik M; Korbut R
J Physiol Pharmacol; 2007 Dec; 58(4):591-610. PubMed ID: 18195475
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular actions of adiponectin: pathophysiologic implications.
Maia-Fernandes T; Roncon-Albuquerque R; Leite-Moreira AF
Rev Port Cardiol; 2008 Nov; 27(11):1431-49. PubMed ID: 19227810
[TBL] [Abstract][Full Text] [Related]
11. The metabolic syndrome and adipocytokines.
Matsuzawa Y
Expert Rev Clin Immunol; 2007 Jan; 3(1):39-46. PubMed ID: 20476950
[TBL] [Abstract][Full Text] [Related]
12. [Significance of renin-angiotensin system in diabetes mellitus with hypertension].
Itoh H
Nihon Rinsho; 2003 Jul; 61(7):1145-53. PubMed ID: 12877076
[TBL] [Abstract][Full Text] [Related]
13. [Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].
Kopff B; Jegier A
Przegl Lek; 2005; 62 Suppl 3():69-72. PubMed ID: 16521924
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children.
Ogawa Y; Kikuchi T; Nagasaki K; Hiura M; Tanaka Y; Uchiyama M
Hypertens Res; 2005 Jan; 28(1):51-7. PubMed ID: 15969255
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin and cardiovascular disease: response to therapeutic interventions.
Han SH; Quon MJ; Kim JA; Koh KK
J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
[TBL] [Abstract][Full Text] [Related]
16. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
Tilg H; Moschen AR
Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
[TBL] [Abstract][Full Text] [Related]
17. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals.
Katagiri H; Yamada T; Oka Y
Circ Res; 2007 Jul; 101(1):27-39. PubMed ID: 17615379
[TBL] [Abstract][Full Text] [Related]
18. [Adipocytokines: factors with various suggested functions].
Zhu Y; Huang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):476-80. PubMed ID: 20481343
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.
Schäffler A; Schölmerich J; Büchler C
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231
[TBL] [Abstract][Full Text] [Related]
20. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention.
Zhu W; Cheng KK; Vanhoutte PM; Lam KS; Xu A
Clin Sci (Lond); 2008 Mar; 114(5):361-74. PubMed ID: 18230060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
